Neogenomics (NEO) Non Operating Investment Income (2020 - 2021)
Neogenomics' (NEO) quarterly Non Operating Investment Income came in at $17.8 million in Q3 2021, down 81.61% on a QoQ basis from $96.5 million in Q2 2021.
Neogenomics (NEO) Non Operating Investment Income (2020 - 2021) Analysis & Trends
Neogenomics (NEO) has 2 years of Non Operating Investment Income data on file, last reported at $17.8 million in Q3 2021.
- Quarterly Non Operating Investment Income changed N/A year-over-year to $17.8 million in Q3 2021, while the trailing twelve-month figure through Sep 2022 was $17.8 million (down 84.99% YoY) and the FY2021 annual result came in at $109.3 million, up 2662.58% from the prior year.
- Non Operating Investment Income retreated to $17.8 million in Q3 2021, from $96.5 million in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $96.5 million in Q2 2021 to a low of $4.0 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | Neogenomics | 2.42 Bn | 2.28 Bn | 91.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 17.75 Mn |
| Sep 30, 2021 | 17.75 Mn |
| Jun 30, 2021 | 96.53 Mn |
| Jun 30, 2021 | 96.53 Mn |
| Dec 31, 2020 | 3.96 Mn |
| Dec 31, 2020 | 3.96 Mn |